With Dr Klonoff’s blessings we are happy to share information about this Diabetes Technology Society meeting: Dr. David Klonoff invites you to attend the Hospital Diabetes Meeting May 13, 2014 Hyatt Arlington, Arlington, Virginia (www.diabetestechnology.org/hospital/) Point of Care Blood Glucose Monitors (POC BGMs) are currently being used for purposes other than those cleared by the
Monthly Archives / April 2014
StripSafely asked Who is Accountable for generic test strips. Apparently it is not a academic question. FDA today release a warning titled, “FDA Safety Communication: Shasta Technologies GenStrip Blood Glucose Test Strips May Report False Results“ FDA is advising these Strips not be used. FDA ask retailers to stop selling and remove them from distribution shelves. FDA
FDA hosted a conversation with the diabetes community on meter accuracy. FDA’s Dr. Courtney Lias was interviewed by StripSafely’s Bennet Dunlap. It is online now! At FDA’s Patient Network. Note to iOS users, the FDA site uses Flash. Watch and Comment to FDA. Please share on social media with the hashtag #DOCasksFDA.
FDA considers a glucose meter and strips a complete system. When a third party manufacturer makes test strips for a meter, who do you think should be responsible for a problem: the meter company, the strip company or the patient for not seeing the fine print and matching the meter with the correct production date
StripSafely welcomes Guest Blogger, Certified Diabetes Educator and Champion of People with Diabetes, Hope Warshaw. We support quality diabetes education – It is how patients learn to StripSafely. As you well know taking on the role of advocate and activist for what we believe is right and just for people with diabetes is crucial.